Palliative Care: End of Life
Episode Notes
National Quality Forum definition of “poor death”
Receiving chemotherapy in the last 14 days of life
Being admitted to the ICU within the last 30 days of life
Dying from cancer without admission to hospice or within 3 days of admission to hospice
Prognosis
3 realms: curability, response to treatment, survival
Before answering questions about prognosis, clarify which information the patient desires
Affects life choices, goals of care, and impacts clinical outcomes
Informative conversations improve mental health, quality of death, and allow for better bereavement adjustment in their caregivers
Honesty and hope are not mutually exclusive!
Framework for Prognosis Conversations
“Best case scenario, worst case scenario, most likely scenario”
Any mention of the future can be an opportunity to talk about prognosis
Ideal times to bring this up… end of upfront treatment, change in treatment due to progression
Strategies for Prognostication
We are notoriously bad as physicians…
Physicians overestimate prognosis by 3-5 fold when communicating with patients near the end of life - more pronounced when doctors and patients have longer preexisting relationships
Overall Survival Data
Use published research matched to your patients (but we don’t always have this)
“Cancer survival statistics (however unfavorable) pertain only to populations or cohorts… for individuals, it’s either 0% or 100%” -Dr. Bill Creasman, SGO president 1988
Signs and Symptoms
Decreased performance status, persistent hypercalcemia, CNS metastases, delirium, cachexia, malignant effusions, need for palliative stenting or venting gastrostomy
4Ds: dyspnea, delirium, decline (of performance status), dysphagia
Labs: albumin <3.5 or CRP >10
Physical exam: reduction in maximal hand grip or maximal expiratory pressure
Validated Scoring Systems
Palliative Performance Score (PPS)
Developed by Victoria Hospice Society in Canada in 199
Ranges from 100% (fully functional) to 0% (death) in 10% decrements based on 5 domains
Ambulation, activity level and evidence of disease, self-care, oral intake, level of consciousness
PPS < 70%: pts w/ palliative care needs
PPS ≤ 50%: significant decline, may signal eligibility for hospice
See Appendix A for chart
Palliative Performance Index (PPI)
Predicts survival time
PPS + oral intake, presence of edema, dyspnea at rest, delirium
Higher score (6.1-15): shorter life expectancy in terms of days
Lower score (0-4): expectancy in terms of months
See Appendix B for chart
Conversation Framework
“Set the Stage”: schedule sufficient time, find a chair for everyone to sit, know where tissues are
ADAPT model
Ask what the patient already knows
Discover what they want to know
Anticipate ambivalence: patients will likely feel worried or ambivalent about the conversation
Provide desired information/ask permission
Use concise, simple language to deliver information; follow with silence
Provide a range - try to not be overly specific
Track emotion and respond
NURSE statements for responding to emotion
Name the emotion
Try to phrase this as a hypothesis vs telling them how they feel
Understand the emotion
Show empathy and try to reflect the patient’s perspective
Respect the patient
Affirm the patient’s strength, values, or efforts
Support the patient
Offer presence or ongoing support
Explore the emotion
Invite the patient to say more
Pitfalls
Missing the patient initiated on-ramp opportunity
I.e. providing information that answers a concrete question (i.e. response rate) without addressing the underlying question
Prematurely abandoning the opportunity to discuss prognosis
Shattering hope by shutting down an outlier outcome
“We would not turn down a miracle” or “I’m hoping for a miracle too”... “I worry…”
Hospice
Definitions
Subset of palliative care that provides end-of-life services to a patient or their family outside of the hospital
Insurance benefit available to people with a life expectancy < 6 months who are no longer pursuing disease-directed therapy
Anyone with a metastatic tumor who is not pursuing disease-directed therapy will be a candidate
Connor et al. 2007, Journal of Pain and Symptom Management
Retrospective study of ~4500 Medicare beneficiaries
Mean survival was 29 days longer for hospice patients vs non-hospice patients
True for lung, pancreatic, colon cancer
No significant difference for breast, prostate cancer
Average Use Times
Median length of stay for pts w/ Medicare: 19 days
¼ of patients receiving hospice die or are discharged from hospice within 7 days
Conversation Framework
Pitfalls
“Stopping treatment”; reframe this as a strategy change - instead of aggressively treating the cancer, the focus shifts to aggressively treating the cancer symptoms (i.e. pain, nausea, shortness of breath)
Benefits/Burdens
Disease-directed therapy: what are the options, what are chances of response, what is the expected response, what are the side effects, symptoms, logistical burdens
Rules
Yes, can un-enroll and re-enroll in hospice as long as they meet eligibility criteria
Maybe can continue to see you in oncology clinic depending on insurance and hospital system policies
What Services?
Different levels
Routine home care (intermittent visits throughout the week)
Continuous home care (at least 8 hours in a 24 hr period)
Adjunctive care in nursing facilities
General inpatient hospice care
Must have symptoms uncontrolled at home, have prognosis of hours or shot days, and/or a preference to not die at home
Insurance Coverage
Yes, covers
Comfort-focused medications
Durable medical equipment (i.e. hospital bed, bedside commode)
Clinical services from interdisciplinary team (physician/APP, RN (available 24/7 by phone), social worker, chaplain)
Limited hours for home health aide (~3 hrs per day up to 4 days per week on average)
Occasional respite care for family members
Bereavement support
No, does not cover
Nursing home room and board (although adjunctive hospice care can be provided in this setting)
24/7 home care
Palliative procedures - paracentesis, thoracentesis, radiation
Blood transfusions
Other conditions?
Insurance-related hospice benefits only cover care related to the hospice diagnosis
Coverage for other medical conditions is highly variable from hospice to hospice and insurance to insurance (i.e. antibiotics, anticoagulation)
Medical Aid in Dying (MAID)
“A medical practice in which a terminally-ill adult of sound mind may ask for and receive a prescription medication they may self-administer for a peaceful death if and when their suffering becomes unbearable”
Legal in 10 states in the US
Requirements
Adult
Terminally ill with a life expectancy of <= 6 months
Mentally sound (able to make health care decisions and understand consequences)
Able to administer their own medication
Process
About 5-15 minutes to reach unconsciousness; 25 minutes - 3 hours to die
Stats
~60% of patient who receive rx for MAID will ultimately use it
70% of Americans agree w/ MAID policies
NCCN Guidelines
Make sure palliative care needs of the patient are being met
Assess symptoms, any psych issues, relationship, values, worries for caregiver burden
Address request explicitly
If a patient uses a euphemism for death or refers to death indirectly, ask for clarification
Distinguish the will not to live in the current state from a wish for a hastened death
Make sure you know your state laws
Death and Dying
“Syndrome of Imminent Death”
Stereotypical pattern of symptoms that most patients experience in the days leading up to death; aka “active dying”
Variable amount of time - less than 24 hours to 14 days
Stages
Early: bed bound, lose ability to eat/drink, cognitive changes (increased time sleeping or w/ delirium)
Middle: longer periods of obtundation (with brief periods of wakefulness w/ slowness to arose w/ stimulation), decreased UOP
Late: pooling of oral secretions due to loss of swallowing reflex (“death rattle”), periods of apnea or hyperpnea, neck hyperextension, coma, fever, mottled extremities
Interventions for comfort
Oral secretions
Non-pharm: Stop all IV fluids and enteral feeding; use gentle oropharyngeal suction, reposition in lateral position, counsel family that patient is not bothered by this
Pharm: muscarinic receptor blockers (i.e. scopolamine)
Delirium
Only treat if causing distress/discomfort to patient
Pharm: 1st gen antipsychotics (haloperidol, chlorpromazine)
IV and SQ haldol option cause less extrapyramidal symptoms but worse QTc prolongation
Chlorpromazine more sedating than haldol
2nd gen aren’t more effective but may be better in pt w/ h/o extrapyramidal reactions
Use benzos with caution - can make delirium worse or precipitate withdrawal symptoms; only use if significant anxiety component
Dyspnea
Ddx: obstructive airway processes, metastases, effusions, pneumonia, drug reactions, emboli, SVC obstruction, heart failure, pericardial effusions, arrhythmias, restrictive processes
Non-pharm: upright position, increasing air movement in room or using fan directed toward the face, bedside relaxation techniques, breathing techniques (pursed lip breathing, diaphragmatic breathing)
O2 only helpful if associated hypoxemia
Pharm: opioids ae drug of choice
Dosing depends on opioid tolerance
Opioid naive: 1-2 mg IV morphine
If severe: 1-3 mg IV every 30 min to 1 hr or a PCA
Educate families that dyspnea mgmt w/ opioids does not hasten death and is not being prescribed for that reason
Antitussives for cough, anticholinergics for secretions, anxiolytics
Pain
Include a basal/hourly dose at this phase of care
Total: basal/hourly rate + patient-directed boluses + nurse/provider-directed bolus
Give a loading dose when starting infusion since can take many hours to reach steady state
In comfort-care setting, dose frequency is allowed to be closer together
Don’t change the basal rate more frequently than every 8 hours
If pts develop anuria or have significant kidney dysfunction close to death, discontinue basal rate to avoid metabolite accumulation, agitated delirium, myoclonus, and allodynia
Hunger and Thirst
One of the most difficult things for families/caregivers
40-90% of dying patients report significant thirst
Important to differentiate between thirst and dry mouth
Offer daily oral care and sips of oral fluid for comfort
Loss of oral intake is not uncomfortable for patients
For families, concern about nutrition is really a statement about grief or loss
In end stages of life, artificial nutrition or hydration can lead to worsening GI discomfort, nausea, loose stooling (which can lead to skin breakdown), aspiration, volume overload symptoms
All of these end of life care practices that we have discussed today are intended to support peaceful death - one that aligns with the patient’s and family’s definition - often centered on freedom from pain, spiritual peace, and the presence of loved ones - a goal that is equally valued by use, their healthcare providers, who are committed to honoring them in dying and in death.
Appendix A
Palliative Performance Scale (PPS) Example
Appendix B
Palliative Prognostic Scale (PPI) example
Reference List
1. Bakitas MA, Tosteson TD, Li Z, et al. Early Versus Delayed Initiation of Concurrent Palliative Oncology Care: Patient Outcomes in the ENABLE III Randomized Controlled Trial. J Clin Oncol 2015;33(13):1438–1445; doi: 10.1200/JCO.2014.58.6362.
2. Wright AA, Zhang B, Alaka Ray M, et al. Associations Between End-of-Life Discussions, Patient Mental Health, Medical Care Near Death, and Caregiver Bereavement Adjustment. JAMA 2008;300(14):1665.
3. Nicholson AB, Watson GR, Derry S, et al. Methadone for cancer pain. Cochrane Database of Systematic Reviews 2017;2017(2); doi: 10.1002/14651858.CD003971.PUB4/MEDIA/CDSR/CD003971/IMAGE_T/TCD003971-AFIG-FIG03.PNG.
4. Vilkins AL, Sahara M, Till SR, et al. Effects of Shared Decision Making on Opioid Prescribing after Hysterectomy. Obstetrics and Gynecology 2019;134(4):823–833; doi: 10.1097/AOG.0000000000003468.
5. Nelson G, Fotopoulou C, Taylor J, et al. Enhanced recovery after surgery (ERAS®) society guidelines for gynecologic oncology: Addressing implementation challenges-2023 update-NC-ND license (http:// creativecommons.org/licenses/by-nc-nd/4.0/). Gynecol Oncol 2023;173:58–67; doi: 10.1016/j.ygyno.2023.04.009.
6. Roeland EJ, Bohlke K, Baracos VE, et al. Management of Cancer Cachexia: ASCO Guideline. 2020.
7. Murphy JD, Triplett DP, Lebrett WG, et al. Effect of Palliative Care on Aggressiveness of End-of-Life Care Among Patients With Advanced Cancer Special Series: Palliative Care ORIGINAL CONTRIBUTION Special Series: Palliative Care ORIGINAL CONTRIBUTION ASSOCIATED CONTENT Effect of Palliative Care on Aggressiveness of End-of-Life Care Among Patients With Advanced Cancer. 2017; doi: 10.1200/JOP.
8. Childers JW, Back AL, Tulsky JA, et al. REMAP: A framework for goals of care conversations. J Oncol Pract 2017;13(10):e844–e850; doi: 10.1200/JOP.2016.018796.
9. Anonymous. Home - VitalTalk. n.d. Available from: https://www.vitaltalk.org/ [Last accessed: 4/27/2025].
10. von Gunten CF. Discussing do-not-resuscitate status. J Clin Oncol 2001;21(9 Suppl); doi: 10.1200/JCO.2003.01.159.
11. Anonymous. The Conversation Project - Staff. n.d. Available from: https://theconversationproject.org/about/ [Last accessed: 4/27/2025].
12. Anonymous. Advance Care Planning: Advance Directives for Health Care | National Institute on Aging. n.d. Available from: https://www.nia.nih.gov/health/advance-care-planning/advance-care-planning-advance-directives-health-care [Last accessed: 4/27/2025].
13. Anonymous. Fast Facts | Palliative Care Network of Wisconsin | Edited by Sean Marks, MD | Directory | Quiz. n.d. Available from: https://www.mypcnow.org/fast-facts/ [Last accessed: 4/27/2025].
14. Anonymous. Forms for Patients and Providers | Washington State Department of Health. n.d. Available from: https://doh.wa.gov/data-and-statistical-reports/health-statistics/death-dignity-act/forms-patients-and-providers [Last accessed: 4/27/2025].
15. Peberdy MA, Kaye W, Ornato JP, et al. Cardiopulmonary resuscitation of adults in the hospital: A report of 14 720 cardiac arrests from the National Registry of Cardiopulmonary Resuscitation. Resuscitation 2003;58(3):297–308; doi: 10.1016/S0300-9572(03)00215-6.
16. Kazaure HS, Roman SA, Sosa JA. Epidemiology and outcomes of in-hospital cardiopulmonary resuscitation in the United States, 2000-2009. Resuscitation 2013;84(9):1255–1260; doi: 10.1016/j.resuscitation.2013.02.021.